• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number TEXP140RH
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/21/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.The device history record (dhr) was reviewed on 6/5/2018, and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.(b)(4).
 
Event or Problem Description
It was reported that a (b)(6) female patient underwent breast reconstruction with a artoura breast tissue expander 600cc.While implanting then inflating, the physician noted the tissue expander was leaking.As a result, the tissue expander was replaced intra-operatively with an artoura breast tissue expander 600cc.No patient consequence nor procedural delay was reported.
 
Additional Manufacturer Narrative
On 6/28/2018, mentor received additional information: explantation date: (b)(6) 2018.Implantation date: (b)(6) 2018.The mentor failure analysis lab received the device for evaluation on 6/22/2018.Device evaluation summary: the device was received at mentor without fluid.No foreign material was observed within the device or on the shell surface.Upon initial inspection, the device appeared intact.Leak testing of the device, in accordance with mentor procedures, revealed no leakage sites.No anomalies were observed.The complaint was not confirmed.Mentor performs 100% inspection and testing of all devices prior to release.A possible cause of the failure could not be determined.The device history record (dhr) for the lot number 7571477 has been reviewed and it was verified that the device was manufactured in accordance with documented specifications and procedures.Breast implants are not considered lifetime devices and deflation is a known complication associated with these devices and is referenced in our product insert data sheet.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTOURA BREAST TISSUE EXPANDER
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key7589197
Report Number1645337-2018-03615
Device Sequence Number16499922
Product Code LCJ
UDI-Device Identifier00081317009498
UDI-Public00081317009498
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date (Section B) 05/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/16/2022
Device Catalogue NumberTEXP140RH
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/22/2018
Initial Date Received by Manufacturer 05/24/2018
Supplement Date Received by Manufacturer05/24/2018
Initial Report FDA Received Date06/11/2018
Supplement Report FDA Received Date07/13/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age41 YR
-
-